Back to company

HEMACAPE ApS: Financial statements 2020

CVR: 35817115

HEMACAPE ApS (CVR 35817115) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -3,375 and a net result of DKK -3,375 compared with DKK -3,364 the year before. Equity amounted to DKK 89,716. The solvency ratio was 79.5%.

Gross Profit
-3,375 kr.
Profit/Loss
-3,375 kr.
Equity
89,716 kr.
Total Assets
112,917 kr.
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--3 t.-3 t.90 t.0
2019--3 t.-3 t.93 t.-
2018--3 t.-3 t.96 t.-
2017--3 t.-3 t.99 t.-
2016--3 t.-3 t.102 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is HEMACAPE ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

HEMACAPE ApS: The 2019 annual report is outJun 18, 2020

HEMACAPE ApS has published its annual report for 2019. Gross profit came to DKK -3,250, and the net result was DKK -3,364.

About HEMACAPE ApS

HEMACAPE ApS is a Danish company of the type Anpartsselskab based in Randers NØ, founded in 2014. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of John Holflod Jeppesen. The company is owned by John Holflod Jeppesen. In 2025, the company reported a gross profit of DKK -5,843 and a net result of DKK 537,377 compared with DKK -3,750 the year before. Equity amounted to DKK 612,350.